SiteOne Therapeutics competitorsClear all
SiteOne Therapeutics's top competitors include Dermala, Peptilogics, Eternygen and Biohaven Pharmaceutical.
| Save Comparison |  SiteOne Therapeutics SiteOne Therapeutics is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids |  Dermala Dermala, a spinout from the University of California San Diego, is utilizing the human microbiome to develop novel, natural, safe, and effective products to treat chronic skin diseases and enhance skin health. |  Peptilogics Peptilogics is an early stage biotech company developing a breakthrough technology platform in the antimicrobial segment. |  Eternygen Eternygen is focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations. |  Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. |
Founding Date | Founding Date 2010 | Founding Date 2014 | Founding Date 2013 | Founding Date 2012 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Bozeman, US HQ Bozeman, US | Locations San Diego, US HQ | Locations Pittsburgh, US HQ | Locations Berlin, DE HQ Berlin, DE Edinburgh, GB | Locations New Haven, US HQ |
Employees | Employees N/A | Employees 9 | Employees 1011% increase | Employees 6 | Employees 8051% increase |
Twitter followers | Twitter followers N/A | Twitter followers 665 | Twitter followers 202 | Twitter followers N/A | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 1 | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 309822 | Alexa Website Rank 244327 | Alexa Website Rank N/A | Alexa Website Rank 231538 |
Funding | |||||
Latest funding round | Latest funding round $ 15m (about 4 years ago) | Latest funding round $ 1m (almost 3 years ago) | Latest funding round $ 35.4m (3 months ago) | Latest funding round $ 8.4m (about 4 years ago) | Latest funding round $ 80m (over 4 years ago) |
Total funding raised | Total funding raised $ 17.8m | Total funding raised $ 1m | Total funding raised $ 41.3m | Total funding raised $ 8.4m | Total funding raised $ 80m |
For sources of this data, please see the company profile
View company profiles
Dermala
HQ
San Diego, US
Employees
9
Dermala, a spinout from the University of California San Diego, is utilizing the human microbiome to develop novel, natural, safe, and effective products to treat chronic skin diseases and enhance skin health.
View companyPeptilogics
HQ
Pittsburgh, US
Employees
10↑ 11% increase
Peptilogics is an early stage biotech company developing a breakthrough technology platform in the antimicrobial segment.
View companyEternygen
HQ
Berlin, DE
Employees
6
Eternygen is focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations.
View companyBiohaven Pharmaceutical
HQ
New Haven, US
Employees
805↑ 1% increase
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
View company